93
Views
9
CrossRef citations to date
0
Altmetric
Short Report

Pediatric neurofibromatosis 1 and parental stress: a multicenter study

, , , , , & show all
Pages 141-146 | Published online: 22 Jan 2014

Abstract

Background

Neurofibromatosis 1 (NF1) is a complex and multifaceted neurocutaneous syndrome with many and varied comorbidities. The literature about the prevalence and degree of maternal stress and the impact of NF1 in the parent–child interaction is still scant. The aim of this study was to evaluate the prevalence of maternal stress in a large pediatric sample of individuals affected by NF1.

Methods

Thirty-seven children (19 boys, 18 girls) of mean age 7.86±2.94 (range 5–11) years affected by typical NF1 and a control group comprising 405 typically developing children (207 boys, 198 girls; mean age 8.54±2.47 years) were included in this study. To assess parental stress, the mothers of all individuals (NF1 and comparisons) filled out the Parenting Stress Index-Short Form test.

Results

The two study groups were comparable for age (P=0.116), gender (P=0.886), and body mass index adjusted for age (P=0.305). Mothers of children affected by NF1 reported higher mean Parenting Stress Index-Short Form scores on the Parental Distress domain (P<0.001), Difficult Child domain (P<0.001), and Total Stress domain than the mothers of typically developing children (controls) (P<0.001). No significant differences between the two groups were found for the Parent-Child Dysfunctional Interaction domain (P=0.566) or Defensive Responding domain scores (P=0.160).

Conclusion

NF1 is considered a multisystemic and complex disease, with many still unrecognized features in pediatric patients and in their families. In this light, our findings about the higher levels of maternal stress highlight the importance of considering the environmental aspects of NF1 management in developmental age.

Introduction

Neurocutaneous syndromes are a group of genetic pathologies linked to the common alteration in development of neural crest.Citation1 In general, the primary neurocutaneous syndromes are all very different diseases with different genetic mutations, but the unifying factor amongst them is that all are neurocristopathies and can be explained as such, including the tumor-suppressor function of several of these genes, especially those of neurofibromatosis 1 and 2 and tuberous sclerosis complex.Citation1

NF1 (OMIM #162200)Citation2 was first described in 1882 by von Recklinghausen, and is among the most common autosomal dominant disorders, with a prevalence of one in 4,000 individuals worldwide,Citation3,Citation4 caused by the NF1 gene mutation coded by chromosome 17q11.2, with the subsequent alteration in Ras-mediated cell proliferation modulation.Citation5,Citation6

Nervous system involvement in NF1 can cause learning disabilities; plexiform neurofibromas; megalencephaly; cerebral tumors; headache; acqueductal stenosis; cerebrovascular disease; meningoceles; neurofibromatous neuropathy; and cerebral high-signal lesions, visible on T2-weighted magnetic resonance images.Citation7Citation10 The varied clinical NF1 manifestations could significantly impact family relationships, as described by Ablon in 2000, who, in 16 families studied, reported shock, upset, and subsequent depression as responses to NF1 diagnosis,Citation11 pinpointing the relevance of the parents’ emotional reactions in NF1 management. On the other hand, behavioral aspects and parental stress of children and adolescents with several disabling genetic and/or chronic conditions were previously described,Citation12,Citation13 and the role of parental stress in the management of childhood chronic illnessesCitation14Citation17 was demonstrated.

To date, reports concerning the impact of neurocutaneous syndrome in parental stress management and parent–child interactions are scant. Therefore, the aim of the present study was to assess the maternal stress levels in a population of school-aged children affected by NF1.

Materials and methods

Study population

The study population comprised 37 children (19 boys, 18 girls) of mean age 7.86±2.94 (range 5–11) years affected by typical NF1 and referred consecutively to the Clinic of Child and Adolescent Neuropsychiatry at the Second University of Naples, to the Department of Psychiatry at the “Magna Graecia” of Catanzaro University and to the Child Neuropsychiatry of the Department of Psychology at the University of Palermo from January 2012 to September 2013.

The diagnosis of NF1 was made according to the clinical criteria, established by the National Institutes of Health consensus in 1987Citation18,Citation19 and the reassessed version of 1997.Citation20

The control group was composed of 405 typically developing controls (207 boys, 198 girls; mean age 8.54±2.47 years) recruited from schools in the Campania and Umbria regions of Italy. Subjects of both groups were recruited from the same urban area, and were all of Caucasian origin and of middle socioeconomic status (within class 2 or class 3, corresponding to €28,000–€55,000/year and €55,000–€75,000/year, respectively, according to current Italian economic parameters), as previously reported.Citation21

For both populations, the exclusion criteria were the following: allergies; endocrinological problems (eg, diabetes); preterm birth;Citation22,Citation23 epilepsy; psychiatric symptoms (such as attention deficit hyperactivity disorder, depression, and behavioral problems); mental retardation (IQ≤70); previous rehabilitative treatment;Citation24 borderline intellectual functioning (IQ ranging from 71–84);Citation25,Citation26 overweight (body mass index [BMI] ≥85th percentile) or obesity (BMI ≥95th percentile);Citation27,Citation28 sleep disorders;Citation29Citation34 primary nocturnal enuresis;Citation35Citation37 and psychoactive drug administration.Citation38,Citation39

All parents gave their written informed consent. The Clinical Departmental University Ethics Committee at the Second University of Naples approved the study protocol, and the study was conducted according to the criteria of the Declaration of Helsinki as modified in 2000.Citation40

Parenting Stress Index-Short Form (PSI-SF)

To assess the perceived stress in mothers of children with NF1, the Italian version of the PSI-SF was used.Citation41 The PSI-SF is a standardized tool that yields scores for parental stress across four areas via Parental Distress and Parent-Child Dysfunctional Interaction domains and Difficult Child and Total Stress subscales. It has 36 items and provides both raw and percentile scores. Each item is graded on a five-point Likert scale, from 1 (strongly disagree) to 5 (strongly agree).

The Parental Distress domain measures the distress that parents feel about their parenting role in light of other personal stresses, and has a cut-off score of 36; the Parent-Child Dysfunctional Interaction domain focuses on the perception of the child as not responsive to parental expectations, and has a cut-off score of 27; and the Difficult Child subscale represents behaviors that children often engage in that may make parenting easier or more difficult, and has a cut-off score of 36.

The PSI-SF also produces a Defensive Responding subscale score, which indicates likely response bias. The subscale scores range from 12 to 60, and the Total Stress subscale scores ranges from 36 to 180, with higher scores indicating greater levels of parental stress. Thus, responses higher than the 85th percentile (one standard deviation above the mean) are interpreted as “clinically significant” for high levels of family stress.Citation41

The PSI-SF has been used widely, and psychometric evidence supports its reliability and validity.Citation37,Citation38 The PSI-SF shows high internal consistency (Cronbach’s alpha 0.92), and its validity has been established in parents of children with chronic medical conditions, including diabetes and asthma.Citation42Citation44 In this study, the PSI-SF was administered only to the mother, being the parent assumed to usually spend more time with the children.

Statistical analysis

The t-test and chi-square test were applied as appropriate to compare the characteristics (age, gender and BMI adjusted for age) and the PSI-SF results between the two populations. P-values <0.05 were considered to be statistically significant.

All data were coded and analyzed using the commercially available STATISTICA package for Windows (v 6.0; StatSoft Inc, Tulsa, OK, USA).

Results

The two study groups were comparable for age (P=0.116), gender (P=0.886), and BMI adjusted for age (P=0.305), as shown in .

Table 1 Age, gender and z-score Body Mass Index (z-BMI) differences between children affected by neurofibromatosis 1 (NF1) and typically developing children (controls)

Mothers of children affected by NF1 reported higher mean PSI-SF scores on the Parental Distress domain (P<0.001), Difficult Child subscale (P<0.001), and Total Stress subscale score (P<0.001) than the mothers of typically developing children, as shown in .

Table 2 Differences in PSI-SFCitation42 domain scores between mothers of children with NF1 and mothers of normal healthy controls

No relevant differences between the two groups were found for the Parent-Child Dysfunctional Interaction domain (P=0.566) or Defensive Responding domain scores (P=0.160) ().

Discussion

The main finding of the present study was that there were higher stress levels in mothers of children affected by NF1 compared with mothers of healthy children (33.19±11.02 vs 26.94±5.44; P<0.001) and in the Difficult Child subscale (26.14±5.03 vs 22.96±3.19; P<0.001), even though their scores did not fall within the pathological ranges.

To interpret and understand these findings correctly, we could speculate that, while NF1 is an autosomal dominant condition, one half of all cases are thought to represent de novo mutations, with clinical characteristics that are often frightening for parents and unpredictable symptom progression.Citation11 In this light, our results about the higher quote of the parental stress total level and in the Difficult Child subscale may be interpreted.

NF1 is an extremely variable condition, the morbidity and mortality of which is largely dictated by complications that are numerous and can involve any body system;Citation3,Citation4,Citation45 the stress of mothers of NF1 children may be interpreted as linked to the varied comorbidities of the illness. Moreover, the prognosis of NF1 remains unpredictable, with the possibility of complications affecting various organs, such as central nervous system cancer that can also involve the PTEN gene functions, even if not exclusively.Citation46Citation48

NF1 affects all aspects of a child’s life, because it is associated with cognitive impairment, learning disabilities, and neuropsychological deficits;Citation49Citation55 sleep alterations; and hyperactivity.Citation56 NF1 also contributes to parental distress and affects family functioning,Citation57,Citation58 both of which could be influenced by parents’ consideration of the child as “different” from other children, even if in an undefined way.

We could speculate that the high stress levels identified in mothers of NF1 children could be due not only to the specific characteristic of the NF1, that can be physically disfiguring, but also to the frequent clinical hospital controls, as with other chronic illness (eg, diabetes, asthma, primary ciliary dyskinesia, cystic fibrosis, migraine, and celiac disease).Citation17,Citation59Citation63 Specifically, parents of children affected by other genetic chronic illnesses seem to experience higher stress levels and greater burdens than parents of healthy children, yet parenting behavior and family functioning have been found to be quite similar to those of healthy control groups.Citation61,Citation62

In general, we can assume that, when a child is diagnosed with a chronic, life-threatening illness, there is a significant impact on the other family members, and the stress of parenting tends to reflect the level of stress/difficulty present in the parent–child relationship, including stress attributable to parental distress, difficult child characteristics, and dysfunctional parent–child interactions. Notably, research conducted by Hung et al in 2004Citation64 suggested that different illnesses may result in different levels of stress of parenting, ie parenting of children affected by chronic illness can be a stressful condition in itself, becoming a vicious circle.

Conflict over child care responsibilities and decision-making are the most commonly reported stresses experienced by parents caring for children with a chronic illness.Citation65Citation67 In 2010, Hullmann et al reported that parents of children with asthma who experience strained interactions with their child or are highly critical of their children are less likely to engage in effective disease management strategies and have children with more severe asthma.Citation68 Therefore, these studies suggest that children’s health outcomes are related to how well their parents function and adhere to the prescribed regimen. This seems to be particularly important for parents of children with cystic fibrosis, diabetes, and asthma, as most of the daily treatments are performed by parents.Citation68

The toll that NF1 takes on families may be identified also in the oncologic potential of NF1 leads per se, linked to the role of neurofibromin protein as a tumor-suppressor gene and inhibitor of the Ras/mitogen-activated protein kinase pathway that is an important regulator of cellular growth and differentiation, aiding the dephosphorylation of ras guanosine triphosphate.Citation69 In this perspective, the high maternal stress levels, expressed as difficult child perception (26.14±5.03 of NF1 mothers versus 22.96±3.19 of mothers of comparisons, P<0.001), could also represent as the effect of the fear for life-threatening complications, such as cancer.

On the other hand, we have to clarify that the higher stress levels in mothers of NF1 children respect of mother of comparisons were not in the pathological range. In this light, these findings suggest that psychological support for parents with children affected by NF1 could help to prevent the developing of clinically evident difficulties in parent– child interactions that could further worsen the quality of life of children affected by NF1.

We should take into account some limitations of this study: 1) our data were derived from a small group affected by NF1 from a specific region of southern Italy; and 2) the assessment of parental stress levels was undertaken only in the mothers.

Notwithstanding these limitations, this could be considered a first report about parental stress evaluation in NF1, which is a multisystemic and complex disease with many still unrecognized features in pediatric patients and in their families. Our findings about the higher levels of maternal stress highlight the importance of considering the environmental aspects of NF1 management in developmental age, and suggest that specific psychological support could be of benefit to pediatric NF1 patients and their families.

Disclosure

The authors report no conflicts of interest in this work.

References

  • SarnatHBFlores-SarnatLGenetics of neural crest and neurocutaneous syndromesHandb Clin Neurol201311130931423622181
  • OMIMOnline Mendelian Inheritance in MenMcKusick catalog of human genes [webpage on the Internet]Baltimore, MDJohns Hopkins University Press2004 Available from: http://www.omim.org/entry/162200
  • HughesRAHusonSMThe Neurofibromatoses: A Pathogenetic and Clinical OverviewLondonChapman and Hall Medical1994
  • FriedmanJMGutmannDHMacCollinMDRiccardiVMNeurofibromatosis: Phenotype, Natural History, and PathogenesisBaltimore, MDJohns Hopkins University Press1999
  • UpadhyayaMCooperDMNeurofibromatosis Type 1: From Genotype to PhenotypeOxfordBios Scientific1998
  • AshwalSRustRChild neurology in the 20th centuryPediatr Res20035334536112538797
  • RuggieriMThe different forms of neurofibromatosisChilds Nerv Syst19991529530810461778
  • HughesRANeurological complications of neurofibromatosis type 1HughesRAHusonSMThe Neurofibromatoses: A Pathogenetic and Clinical OverviewLondonChapman and Hall Medical1994204232
  • CréangeAZellerJRostaing-RigattieriSNeurological complications of neurofibromatosis type 1 in adulthoodBrain199912247348110094256
  • CarotenutoMEspositoMNutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type INeurol Sci201334111905190923532548
  • AblonJParents’ responses to their child’s diagnosis of neurofibromatosis 1Am J Med Genet200093213614210869117
  • GlasscoeCAQuittnerALPsychological interventions for people with cystic fibrosis and their familiesCochrane Database Syst Rev2008163CD00314818646087
  • EspositoMGallaiBParisiLMaternal stress and childhood migraine: a new perspective on managementNeuropsychiatr Dis Treat2013935135523493447
  • VealeBMMeeting the challenge of chronic illness in general practiceMed J Aust200317924724912924971
  • EddyMECarterBDKronenbergerWGParent relationships and compliance in cystic fibrosisJ Pediatr Health Care19981241962029832734
  • SpiethLEStarkLJMitchellMJObservational assessment of family functioning at mealtime in preschool children with cystic fibrosisJ Pediatr Psychol200126421522411329481
  • CarotenutoMEspositoMDi PasqualeFDe StefanoSSantamariaFPsychological, cognitive and maternal stress assessment in children with primary ciliary dyskinesiaWorld J Pediatr20139431231724235065
  • [No authors listed]Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development ConferenceArch Neurol199845575578
  • HachonCIannuzziSChaixYBehavioural and cognitive phenotypes in children with neurofibromatosis type 1 (NF1): the link with the neurobiological levelBrain Dev2011331526120106617
  • GutmannDHAylsworthACareyJCThe diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2JAMA1997278151579207339
  • EspositoMVerrottiAGimiglianoFMotor coordination impairment and migraine in children: a new comorbidity?Eur J Pediatr2012171111599160422673929
  • GuzzettaAPizzardiABelmontiVHand movements at 3 months predict later hemiplegia in term infants with neonatal cerebral infarctionDev Med Child Neurol201052876777219863639
  • GuzzettaAD’AcuntoMGCarotenutoMThe effects of preterm infant massage on brain electrical activityDev Med Child Neurol201153Suppl 4465121950394
  • EspositoMGimiglianoFRubertoMPsychomotor approach in children affected by nonretentive fecal soiling (FNRFS): a new rehabilitative purposeNeuropsychiatr Dis Treat201391433144124092981
  • EspositoMCarotenutoMIntellectual disabilities and power spectra analysis during sleep: a new perspective on borderline intellectual functioningJ Intellect Disabil Res201310.1111/jir.12036In press
  • EspositoMCarotenutoMBorderline intellectual functioning and sleep: the role of cyclic alternating patternNeurosci Lett201019485(2)8993
  • CarotenutoMSantoroNGrandoneAThe insulin gene variable number of tandemrepeats (INS VNTR) genotype and sleep disordered breathing in childhood obesityJ Endocrinol Invest200932975275519574727
  • CarotenutoMBruniOSantoroNDel GiudiceEMPerroneLPascottoAWaist circumference predicts the occurrence of sleep-disordered breathing in obese children and adolescents: a questionnaire-based studySleep Med20067435736116713341
  • CarotenutoMGuidettiVRujuFGalliFTaglienteFRPascottoAHeadache disorders as risk factors for sleep disturbances in school aged childrenJ Headache Pain20056426827016362683
  • EspositoMParisiPMianoSCarotenutoMMigraine and periodic limb movement disorders in sleep in children: a preliminary case-control studyJ Headache Pain20131415723815623
  • CarotenutoMGallaiBParisiLRoccellaMEspositoMAcupressure therapy for insomnia in adolescents: a polysomnographic studyNeuropsychiatr Dis Treat2013915716223378768
  • CarotenutoMGimiglianoFFiordelisiGRubertoMEspositoMPositional abnormalities during sleep in children affected by obstructive sleep apnea syndrome: The putative role of kinetic muscular chainsMed Hypotheses201381230630823660129
  • CarotenutoMEspositoMParisiLDepressive symptoms and childhood sleep apnea syndromeNeuropsychiatr Dis Treat2012836937322977304
  • CarotenutoMEspositoMPascottoAFacial patterns and primary nocturnal enuresis in childrenSleep Breath201115222122720607423
  • EspositoMGallaiBParisiLPrimary nocturnal enuresis as a risk factor for sleep disorders: an observational questionnaire-based multicenter studyNeuropsychiatr Dis Treat2013943744323579788
  • EspositoMCarotenutoMRoccellaMPrimary nocturnal enuresis and learning disabilityMinerva Pediatr20116329910421487372
  • EspositoMGallaiBParisiLVisuomotor competencies and primary monosymptomatic nocturnal enuresis in prepubertal aged childrenNeuropsychiatr Dis Treat2013992192623847418
  • CoppolaGAuricchioGFedericoRCarotenutoMPascottoALamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group studyEpilepsia20044591049105315329068
  • CoppolaGLicciardiFSciscioNLamotrigine as first-line drug in childhood absence epilepsy: a clinical and neurophysiological studyBrain Dev2004261262914729411
  • WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects [webpage on the Internet]Ferney-VoltaireWorld Medical Association1964 [amended 1975–2013]. Available from: http://www.wma.net/en/30publications/10policies/b3/Accessed August 5, 2013
  • AbidinRRParenting Stress Index, Third Edition: Professional ManualLutz, FLPsychological Assessment Resources Inc1995
  • AbdinRRParenting Stress Index-Short Form ManualLos Angeles, CAWestern Psychological Services1990
  • CarsonDKSchauerRWMothers of children with asthma: perceptions of parenting stress and the mother-child relationshipPsychol Rep199271113911481480693
  • WysockiTHuxtableKLinscheidTRWayneWAdjustment to diabetes mellitus in preschoolers and their mothersDiabetes Care1989125245292776586
  • CnossenMHMoonsKGGarssenMPMinor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 children < or =6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children’s HospitalJ Med Genet1998356246279719365
  • BanerjeeSCrouseNREmnettRJGianinoSMGutmannDHNeurofibromatosis-1 regulates mTOR-mediated astrocyte growth and glioma formation in a TSC/Rheb-independent mannerProc Natl Acad Sci U S A201110838159961600121896734
  • TadaKKochiMSayaHPreliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1Neuro Oncol20035422823414565158
  • EliaMAmatoCBottittaMAn atypical patient with Cowden syndrome and PTEN gene mutation presenting with cortical malformation and focal epilepsyBrain Dev2012341087387622469695
  • RiccardiVMEichnerJENeurofibromatosis: Phenotype, Natural History, and PathogenesisLondonJohns Hopkins University Press1986
  • ViolanteIRRibeiroMJCunhaGAbnormal brain activation in neurofibromatosis type 1: a link between visual processing and the default mode networkPLoS One201276e3878522723888
  • MautnerVFKluweLThakkerSDLearkRATreatment of ADHD in neurofibromatosis type 1Dev Med Child Neurol20024416417012005317
  • HymanSLArthur ShoresENorthKNLearning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorderDev Med Child Neurol20064897397717109785
  • FriedmanJMBirchPGreeneCNational Neurofibromatosis Foundation International DatabaseAm J Med Genet19934588918418666
  • NorthKNeurofibromatosis type 1Am J Med Genet20009711912711180219
  • LevineTMMaterekAAbelJO’DonnellMCuttingLECognitive profile of neurofibromatosis type 1Semin Pediatr Neurol20061382016818171
  • JohnsonHWiggsLStoresGHusonSMPsychological disturbance and sleep disorders in children with neurofibromatosis type 1Dev Med Child Neurol200547423724215832546
  • Reiter-PurtillJSchorryEKLovellAMVannattaKGerhardtCANollRBParental distress, family functioning, and social support in families with and without a child with neurofibromatosis 1J Pediatr Psychol200833442243417905803
  • NollRBReiter-PurtillJMooreBDSocial, emotional, and behavioural functioning of children with NF1Am J Med Genet A2007143A192261227317726688
  • Koinis-MitchellDMcQuaidELSeiferRSymptom perception in children with asthma: cognitive and psychological factorsHealth Psychol200928222623719290715
  • McCrimmonRJRyanCMFrierBMDiabetes and cognitive dysfunctionLancet201237998332291229922683129
  • IeversCEDrotarDFamily and parental functioning in cystic fibrosisJ Dev Behav Pediatr199617148558675714
  • WalkerLSFordMBDonaldWDCystic fibrosis and family stress: effects of age and severity of illnessPediatrics19877922392463808796
  • Di FilippoTOrlandoMFConcialdiGThe quality of life in developing age children with celiac diseaseMinerva Pediatr201365659960824217629
  • HungJWWuYHYehCHComparing stress levels of parents of children with cancer and parents of children with physical disabilitiesPsychooncology20041389890315624237
  • TaanilaAKokkonenJJärvelinMRThe long-term effects of children’s early-onset disability on marital relationshipsDev Med Child Neurol1996385675778674907
  • QuittnerALOpipariLCEspelageDLCarterBEidNEigenHRole strain in couples with and without a child with a chronic illness: associations with marital satisfaction, intimacy, and daily moodHealth Psychol1998171121249548702
  • HodgkinsonRLesterHStresses and coping strategies of mothers living with a child with cystic fibrosis: implications for nursing professionalsJ Adv Nurs200239437738312139650
  • HullmannSEWolfe-ChristensenCRyanJLParental overprotection, perceived child vulnerability, and parenting stress: a cross-illness comparisonJ Clin Psychol Med Settings201017435736521086027
  • JouhilahtiEMPeltonenSHeapeAMPeltonenJThe pathoetiology of neurofibromatosis 1Am J Pathol20111781932193921457932